Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 3Phase 1/2 1Phase 1 1

Status

Completed 5Active not recruiting 3Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Hepatocellular 1

Interventions

Carboplatin 106Cisplatin 97Paclitaxel 78pembrolizumab 69Gemcitabine 59Pemetrexed 49Cyclophosphamide 46Docetaxel 45Dexamethasone 45durvalumab 44Capecitabine 44Radiotherapy 40Nivolumab 37Lenalidomide 37Specimen Handling 36Doxorubicin 36Rituximab 34Oxaliplatin 34Bevacizumab 33Magnetic Resonance Spectroscopy 32Fluorouracil 32atezolizumab 29Etoposide 29Vincristine 26Radiation 26Leucovorin 26Letrozole 24Bortezomib 24Fulvestrant 23Prednisone 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Active not recruiting × Tiragolumab × Clear all
NCT04543617 2026-04-17

SKYSCRAPER-07

Hoffmann-La Roche

Phase 3 Active not recruiting
760 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04665856 2026-02-13

SKYSCRAPER-02C

Hoffmann-La Roche

Phase 3 Active not recruiting
123 enrolled 26 charts
Thoracic

Small Cell Lung Carcinoma

NCT05904886 2025-12-31

SKYSCRAPER-14

Hoffmann-La Roche

Phase 3 Active not recruiting
687 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡